BR112014023570A2 - Purificação de cistationina beta-sintase - Google Patents
Purificação de cistationina beta-sintaseInfo
- Publication number
- BR112014023570A2 BR112014023570A2 BR112014023570A BR112014023570A BR112014023570A2 BR 112014023570 A2 BR112014023570 A2 BR 112014023570A2 BR 112014023570 A BR112014023570 A BR 112014023570A BR 112014023570 A BR112014023570 A BR 112014023570A BR 112014023570 A2 BR112014023570 A2 BR 112014023570A2
- Authority
- BR
- Brazil
- Prior art keywords
- beta
- purification
- cistationine
- syntase
- synthase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01022—Cystathionine beta-synthase (4.2.1.22)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
purificação de cistationina beta-sintase. a presente invenção refere-se a métodos cromatográficos para a purificação de uma proteína cistationina (beta)-sintase (cbs), particularmente, variantes truncadas da mesma e composições e composições farmacêuticas preparadas a partir da mesma. método que compreende as etapas de fornecer uma solução que contém cbs compreendendo impurezas e executar a separação cromatográfica da mesma.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261615629P | 2012-03-26 | 2012-03-26 | |
US61/615,629 | 2012-03-26 | ||
US13/830,494 | 2013-03-14 | ||
US13/830,494 US9243239B2 (en) | 2012-03-26 | 2013-03-14 | Purification of cystathionine beta-synthase |
PCT/US2013/033716 WO2013148580A1 (en) | 2012-03-26 | 2013-03-25 | Purification of cystathionine beta-synthase |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014023570A2 true BR112014023570A2 (pt) | 2021-06-01 |
BR112014023570B1 BR112014023570B1 (pt) | 2022-03-15 |
Family
ID=49212017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014023570-8A BR112014023570B1 (pt) | 2012-03-26 | 2013-03-25 | Método de purificação da protéina cistationina betasintase (cbs) |
Country Status (11)
Country | Link |
---|---|
US (4) | US9243239B2 (pt) |
EP (3) | EP3569706A1 (pt) |
JP (3) | JP6146934B2 (pt) |
CN (1) | CN104540940B (pt) |
AU (1) | AU2013240003B2 (pt) |
BR (1) | BR112014023570B1 (pt) |
CA (1) | CA2867719C (pt) |
HK (1) | HK1246350B (pt) |
IL (2) | IL234635B (pt) |
IN (1) | IN2014DN07920A (pt) |
WO (1) | WO2013148580A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9034318B2 (en) | 2011-08-30 | 2015-05-19 | The Regents Of The University Of Colorado, A Body Corporate | Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria |
US9243239B2 (en) * | 2012-03-26 | 2016-01-26 | The Regents Of The University Of Colorado, A Body Corporate | Purification of cystathionine beta-synthase |
US9675678B2 (en) | 2013-01-29 | 2017-06-13 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for treatment of homocystinuria |
CA3001625A1 (en) * | 2015-11-09 | 2017-05-18 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for treatment of homocystinuria |
AU2018254410A1 (en) | 2017-04-17 | 2019-10-10 | The Regents Of The University Of Colorado, A Body Corporate | Optimization of enzyme replacement therapy for treatment of homocystinuria |
WO2020264061A1 (en) * | 2019-06-25 | 2020-12-30 | Zymergen Inc. | Engineered biosynthetic pathways for production of cystathionine by fermentation |
EP3990005A1 (en) * | 2019-06-26 | 2022-05-04 | Travere Therapeutics Switzerland GmbH | Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5576559A (en) | 1978-12-01 | 1980-06-09 | Chiyou Lsi Gijutsu Kenkyu Kumiai | Electron beam fine adjusting device |
US5523225A (en) | 1993-09-13 | 1996-06-04 | Regents Of The University Of Colorado | DNA sequence encoding human cystathionine β-synthase |
US5635375A (en) | 1995-01-09 | 1997-06-03 | Regents Of The University Of Colorado | Method of increasing the yield and heme saturation of cystathione β-synthase |
WO2003106971A2 (en) | 2002-06-17 | 2003-12-24 | The Regents Of The University Of Colorado | HUMAN CYSTATHIONINE β-SYNTHASE VARIANTS AND METHODS OF PRODU CTION THEREOF |
GB0216001D0 (en) * | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
EP1396537A1 (en) | 2002-09-04 | 2004-03-10 | Avidis SA | Treatment of elevated plasma homocysteine |
CN1552905A (zh) * | 2003-12-18 | 2004-12-08 | 中国农业科学院茶叶研究所 | 一类茶树胱硫醚-γ-合成酶特异表达序列标签及其生物芯片 |
EP1878739A1 (en) | 2006-07-14 | 2008-01-16 | LEK Pharmaceuticals D.D. | One step IMAC (MCAC) purification of proteins |
CA2788689C (en) | 2010-02-04 | 2019-07-02 | The Board Of Regents Of The University Of Texas System | Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof |
US9243239B2 (en) | 2012-03-26 | 2016-01-26 | The Regents Of The University Of Colorado, A Body Corporate | Purification of cystathionine beta-synthase |
-
2013
- 2013-03-14 US US13/830,494 patent/US9243239B2/en active Active
- 2013-03-25 EP EP19179948.5A patent/EP3569706A1/en not_active Withdrawn
- 2013-03-25 CN CN201380027463.0A patent/CN104540940B/zh active Active
- 2013-03-25 IN IN7920DEN2014 patent/IN2014DN07920A/en unknown
- 2013-03-25 WO PCT/US2013/033716 patent/WO2013148580A1/en active Application Filing
- 2013-03-25 EP EP13716577.5A patent/EP2831229B8/en active Active
- 2013-03-25 BR BR112014023570-8A patent/BR112014023570B1/pt active IP Right Grant
- 2013-03-25 EP EP17165825.5A patent/EP3263701B1/en active Active
- 2013-03-25 AU AU2013240003A patent/AU2013240003B2/en active Active
- 2013-03-25 CA CA2867719A patent/CA2867719C/en active Active
- 2013-03-25 JP JP2015503433A patent/JP6146934B2/ja active Active
-
2014
- 2014-09-14 IL IL234635A patent/IL234635B/en active IP Right Grant
-
2015
- 2015-12-16 US US14/970,814 patent/US10160962B2/en active Active
-
2017
- 2017-04-12 JP JP2017078808A patent/JP6839595B2/ja active Active
-
2018
- 2018-05-03 HK HK18105730.4A patent/HK1246350B/zh unknown
- 2018-11-01 US US16/178,024 patent/US20190055537A1/en not_active Abandoned
- 2018-11-21 IL IL26316218A patent/IL263162B/en active IP Right Grant
-
2019
- 2019-10-11 JP JP2019187777A patent/JP6952361B2/ja active Active
-
2020
- 2020-01-10 US US16/739,169 patent/US10941392B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US10941392B2 (en) | 2021-03-09 |
EP3569706A1 (en) | 2019-11-20 |
EP2831229A1 (en) | 2015-02-04 |
JP6952361B2 (ja) | 2021-10-20 |
US20200131497A1 (en) | 2020-04-30 |
JP2015512639A (ja) | 2015-04-30 |
US20160177287A1 (en) | 2016-06-23 |
US20190055537A1 (en) | 2019-02-21 |
JP6839595B2 (ja) | 2021-03-10 |
HK1246350B (zh) | 2020-05-15 |
EP3263701B1 (en) | 2019-06-19 |
IL263162B (en) | 2019-11-28 |
JP2017121255A (ja) | 2017-07-13 |
US20130251700A1 (en) | 2013-09-26 |
US10160962B2 (en) | 2018-12-25 |
CA2867719A1 (en) | 2013-10-03 |
JP6146934B2 (ja) | 2017-06-21 |
IN2014DN07920A (pt) | 2015-05-01 |
IL234635B (en) | 2018-12-31 |
EP2831229B8 (en) | 2018-10-17 |
EP2831229B1 (en) | 2017-10-18 |
BR112014023570B1 (pt) | 2022-03-15 |
US9243239B2 (en) | 2016-01-26 |
WO2013148580A1 (en) | 2013-10-03 |
CN104540940A (zh) | 2015-04-22 |
AU2013240003B2 (en) | 2018-04-19 |
EP3263701A1 (en) | 2018-01-03 |
AU2013240003A1 (en) | 2014-10-02 |
CN104540940B (zh) | 2018-03-06 |
CA2867719C (en) | 2020-08-11 |
JP2020000259A (ja) | 2020-01-09 |
IL263162A (en) | 2018-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014023570A2 (pt) | Purificação de cistationina beta-sintase | |
MY166016A (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
BR112015031073A2 (pt) | inibidores bicíclicos de bromodomínio | |
BR112013003332A2 (pt) | método para melhorar a estabilidade de intensificador de doce e composição contendo intensificador de doce estabilizado | |
IN2014DN08481A (pt) | ||
MD20150091A2 (ro) | Compuşi antivirali | |
BR112012025729A2 (pt) | purificação por adsorção de caramelo | |
IL221609A (en) | Vitamin k purification process depends on proteins such as coagulation factor ix | |
MX2013002948A (es) | Composiciones farmaceuticas y nutraceuticas de acido abscisico. | |
EA201491195A1 (ru) | Способ получения композиции, содержащей галактоолигосахариды | |
WO2014068586A3 (en) | Solid oral compositions of tolvaptan | |
IN2014DN08412A (pt) | ||
BR112013018298A2 (pt) | compostos para a redução da produção de beta-amiloides | |
ZA201407010B (en) | Process for the preparation of branched polybutadiene having high content of 1,4-cis units | |
BR112015022859A2 (pt) | processo para fabricação de mono-hidrato trissódico gadofosveset | |
BR112013020212A2 (pt) | método de produção de um adoçante natuarl aprimorado | |
EP2844631A4 (en) | PROCESS FOR PURIFYING RAW ACETONE CURRENT | |
MX2013013436A (es) | Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos. | |
WO2012122451A3 (en) | Polymorphs of maxacalcitol and process for the preparation of maxacalcitol | |
EP2924044A4 (en) | PLATINUM COMPOUND AND MALONIC ACID DERIVATIVE HAVING A CONTAINING GROUP CONTAINING AN AMINO OR ALKYLAMINO GROUP | |
BR112015001564A2 (pt) | métodos para a remoção de um ou mais componentes de uma composição ou composições. | |
IN2015DN00725A (pt) | ||
MY187748A (en) | Compositions and method for maintaining/improving cognitive function | |
BR112015014539A2 (pt) | método para purificação de lecitina | |
MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/03/2013, OBSERVADAS AS CONDICOES LEGAIS. |